Home › Funds › PACK Private Wealth, LLC › RPRX
PACK Private Wealth, LLC position in RPRX
ROYALTY PHARMA PLC · Health Care
PACK Private Wealth, LLC reported holding 17,414 shares of RPRX (ROYALTY PHARMA PLC) in its Q2 2026 13F filing — a position valued at US$976K, representing 0.40% of its reported portfolio and ranking #22 among its reported holdings. PACK Private Wealth, LLC has disclosed RPRX holdings in 12 of the last 12 reported quarters, going back to Q3 2023.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How PACK Private Wealth, LLC's RPRX position evolved
PACK Private Wealth, LLC first disclosed a stake in RPRX in Q3 2023 at 17,414 shares (US$467K). The position peaked in Q2 2026 at 17,414 shares, worth US$976K. Across 12 filings, PACK Private Wealth, LLC held the position steady without any share-count change. The most recent filing (Q2 2026) shows 17,414 shares valued at US$976K.
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 17.41K | $466.87K | New |
| Q4 2023 | 17.41K | $489.16K | Hold |
| Q1 2024 | 17.41K | $528.86K | Hold |
| Q2 2024 | 17.41K | $459.21K | Hold |
| Q3 2024 | 17.41K | $492.64K | Hold |
| Q4 2024 | 17.41K | $444.23K | Hold |
| Q1 2025 | 17.41K | $542.10K | Hold |
| Q2 2025 | 17.41K | $627.43K | Hold |
| Q3 2025 | 17.41K | $614.37K | Hold |
| Q4 2025 | 17.41K | $672.88K | Hold |
| Q1 2026 | 17.41K | $835.35K | Hold |
| Q2 2026 | 17.41K | $976.40K | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About RPRX and 13F data
RPRX (ROYALTY PHARMA PLC) is a Health Care company. 50 other funds we track also report a position in RPRX — the largest reported positions include Swedbank AB (US$601.4M), Baillie Gifford & Co (US$561.6M), Caledonia (Private) Investments Pty Ltd (US$323.9M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding RPRX
- Swedbank AB 10.73M sh · $601.44M · Q2 2026
- Baillie Gifford & Co 10.02M sh · $561.57M · Q2 2026
- Caledonia (Private) Investments Pty Ltd 5.78M sh · $323.85M · Q2 2026
- ROYAL LONDON ASSET MANAGEMENT LTD 4.32M sh · $242.20M · Q2 2026
- Patient Capital Management, LLC 3.60M sh · $201.79M · Q2 2026
- Dorsey Asset Management, LLC 2.46M sh · $137.74M · Q2 2026
- Regal Partners Ltd 2.45M sh · $137.25M · Q2 2026
- NEW SOUTH CAPITAL MANAGEMENT INC 2.39M sh · $133.78M · Q2 2026
- Clark Capital Management Group, Inc. 1.66M sh · $93.24M · Q2 2026
- HOMESTEAD ADVISERS CORP 1.66M sh · $92.92M · Q2 2026
- EVENTIDE ASSET MANAGEMENT, LLC 1.38M sh · $77.67M · Q2 2026
More on PACK Private Wealth, LLC
FAQ
How long has PACK Private Wealth, LLC held RPRX?
PACK Private Wealth, LLC has disclosed RPRX holdings in 12 of the last 12 reported quarters, going back to Q3 2023.
What is PACK Private Wealth, LLC's current position in RPRX?
As of Q2 2026, PACK Private Wealth, LLC holds 17.41K shares of RPRX (ROYALTY PHARMA PLC), valued at $976.40K, representing 0.40% of its reported portfolio and ranking #22.
Has PACK Private Wealth, LLC been buying or selling RPRX?
In the latest 13F filing (Q2 2026), PACK Private Wealth, LLC held unchanged its position in RPRX. The position peaked in Q2 2026 at 17.41K shares.
Which other funds hold RPRX?
Other major institutional holders of RPRX include Swedbank AB, Baillie Gifford & Co, Caledonia (Private) Investments Pty Ltd, among 50 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.